Skip to main content
SpringerLink
Log in

D-dimer elevation after first alemtuzumab administration in a multiple sclerosis patient: case report

  • Letter to the Editor
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Libertinova J, Meluzinova E, Nema E, Rockova P, Elisak M, Petrzalka M, Mojzisova H, Hammer J, Tomek A, Marusic P (2021) Elevated D-dimer as an immediate response to alemtuzumab treatment. Mult Scler J 27:151–154. https://doi.org/10.1177/1352458520904277

    Article  CAS  Google Scholar 

  2. Lee DW, Gardner R, Porter DL, Louis CU, Ahmed N, Jensen M, Grupp SA, Mackall CL (2014) Current concepts in the diagnosis and management of cytokine release syndrome. Blood 124:188–195. https://doi.org/10.1182/blood-2016-07-730689

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Killestein J, van Osten B (2019) Emerging safety issues in alemtuzumab treated MS patients. Mult Scler J 25(9):1206–1208. https://doi.org/10.1177/1352458519851219

    Article  CAS  Google Scholar 

  4. Azevedo CJ, Kutz C, Dix A, Boster A, Sanossian N, Kaplan J (2019) Intracerebral haemorrhage during alemtuzumab administration. Lancet Neurol 18:329–331. https://doi.org/10.1016/S1474-4422(19)30076-6

    Article  PubMed  Google Scholar 

  5. Gasparini S, Russo M, Dattola V, Ferlazzo E, Aguglia U (2020) Cryptogenic cerebral venous thrombosis in a multiple-sclerosis-patient treated with Alemtuzumab. Mult Scler Relat Disord 44:102246. https://doi.org/10.1016/j.msard.2020.102246

    Article  PubMed  Google Scholar 

  6. Habek M, Ruška B, Pavičić T, Alduk AM, Gabelić T, Adamec I (2019) Pulmonary embolism during the third cycle of alemtuzumab in a patient with relapsing multiple sclerosis. Mult Scler Relat Disord 35:5–6. https://doi.org/10.1016/j.msard.2019.06.032

    Article  PubMed  Google Scholar 

  7. De Mercanti SF, Rolla S, Matta M, Iudicello M, Franchin E, Clerico M (2019) D-dimer increasing after first alemtuzumab administration in a multiple sclerosis patient. Int J Clin Exp Med Sci 5:67–69. https://doi.org/10.11648/j.ijcems.20190505.12

  8. Papathanasiou A, Abdel-Fahim R, Gilmore C, Evangelou N (2020) Venous thromboembolism in multiple sclerosis: a report of two cases with pulmonary embolism on dimethyl fumarate and available data from adverse event reporting systems. Time to include disease modifying drugs in the equation? Clin Neurol Neurosurg 192:105726. https://doi.org/10.1016/j.clineuro.2020.105726

    Article  PubMed  Google Scholar 

  9. Krajnc N, Brecl Jakob G, Gomezelj S, Šega Jazbec S (2021) Pulmonary embolism in patients with multiple sclerosis treated with teriflunomide: A series of three cases. Clin Neurol Neurosurg 206:106685. https://doi.org/10.1016/j.clineuro.2021.106685

    Article  PubMed  Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Neurology Clinic, University Clinical Center of Serbia, Dr Subotica 6, 11000, Belgrade, Serbia

      Jovana Ivanovic, Sarlota Mesaros, Tatjana Pekmezovic & Jelena Drulovic

    2. Faculty of Medicine, University of Belgrade, Dr Subotica 8, 11000, Belgrade, Serbia

      Sarlota Mesaros & Jelena Drulovic

    3. Institute of Epidemiology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia

      Tatjana Pekmezovic

    Authors
    1. Jovana Ivanovic
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Sarlota Mesaros
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Tatjana Pekmezovic
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Jelena Drulovic
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Jelena Drulovic.

    Ethics declarations

    Conflict of interest

    The authors declared no potential conflicts of interest with respect to research, authorship, and/or publication of this article.

    Human and animal rights

    This article does not contain any studies with animals performed by any of the authors.

    Additional information

    Publisher's Note

    Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Ivanovic, J., Mesaros, S., Pekmezovic, T. et al. D-dimer elevation after first alemtuzumab administration in a multiple sclerosis patient: case report. Acta Neurol Belg 123, 275–277 (2023). https://doi.org/10.1007/s13760-021-01822-y

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s13760-021-01822-y

    Search

    Navigation